Vigipharm
Vigipharm is a France-based private health vigilance company, founded in 1998 in Montpellier, that provides health product safety monitoring services to pharmaceutical and healthcare clients operating under EU regulatory frameworks. The firm employs 11–50 people.
- Company typePrivate
- Founded1998
- HeadquartersMontpellier, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Vigipharm does
Vigipharm is a France-based private health vigilance company that provides health product safety monitoring services, operating in the pharmacovigilance niche. Founded in 1998 and headquartered in Montpellier, the firm has maintained continuous operation for over 25 years with a small team of 11–50 employees. The company's functional role centers on monitoring the safety profile of health products — likely adverse-event collection, case processing, and regulatory reporting support for pharmaceutical, biotech, or medical-device clients operating under French and EU regulatory frameworks (ANSM, EMA).
The business model is consistent with a specialist B2B services firm: revenue is generated through service engagements with healthcare-product manufacturers and possibly CROs, hospitals, or public-health bodies that require outsourced vigilance expertise. No pricing model, go-to-motion, customer logos, product catalog, or technology stack is disclosed in the available data, and the company's website (vigipharm.fr) was inaccessible at the time of capture, returning only a loading/verification page. There is no documented AI, software product, or platform offering — Vigipharm appears to operate as a service organization rather than a technology vendor.
The most material data gaps are operational: no disclosed revenue, no funding history, no management team, no named customers, no partnerships, and no certifications are recorded. These gaps materially limit the depth of any investment-grade assessment and should be resolved through direct diligence (management interview, French registry filings, and reference checks with past clients) before any capital deployment decision.
Vigipharm firmographics
Firmographics- Name
- Vigipharm
- Website
- https://vigipharm.fr
- Company type
- Private
- Founded year
- 1998
- Headcount range
- 11–50 employees
- Short description
- Vigipharm is a France-based private health vigilance company, founded in 1998 in Montpellier, that provides health product safety monitoring services to pharmaceutical and healthcare clients operating under EU regulatory frameworks. The firm employs 11–50 people.
- Ownership category
- akta.pro rank
Vigipharm industry classification
Industry- Product category
- Pharmacovigilance Services
- SIC
- Services-Testing Laboratories (8734)
- akta.pro primary industry
- Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support) (HLAGALAK)
- akta.pro secondary industries
- Literature Monitoring & Social/Digital Media Safety Monitoring (HLAGALAL), Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH)
Keywords
Where Vigipharm is headquartered
LocationHeadquarters
- HQ city
- Montpellier
- HQ country
- France
- HQ region
- Europe
Markets served
Vigipharm business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Vigipharm product offering
Product offeringCore offering
Vigipharm is a health vigilance company that delivers health product safety monitoring services. The firm monitors the safety profile of health products and helps clients detect, evaluate, and manage risks associated with pharmaceutical and other health-related products throughout their lifecycle.
Differentiator
Problem solved
Functional benefit
Products and services
- Health Product Safety Monitoring Vigilance/monitoring service covering the safety of health products, including risk identification and assessment, offered to organizations that manufacture or market pharmaceutical and health products.
Companies that use Vigipharm
Customer profileIdeal customer profiles1 record
Vigipharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Vigipharm competitors and assessment
Company assessmentDirect peers
- Arriello: Drug safety and pharmacovigilance services firm providing end-to-end safety solutions including case processing, aggregate reports, and QPPV — directly comparable niche PV services peer.
- PharSafer: Dedicated pharmacovigilance and regulatory safety services company providing EU QPPV, PSMF support, and safety reporting — closely aligned specialist PV peer to Vigipharm.
- PrimeVigilance: Specialized pharmacovigilance services provider offering QPPV, signal management, PSUR authoring, and literature monitoring to pharma and biotech sponsors — directly comparable niche PV services model to Vigipharm.
- Pharmacovigilance Services Ltd (PVSL): Boutique pharmacovigilance consultancy offering QPPV, signal detection, literature screening, and PSUR services — comparable small specialist PV services model.
Broad incumbents
- Syneos Health: Biopharmaceutical services organization offering integrated clinical and safety/pharmacovigilance solutions — broader incumbent addressing overlapping PV service needs.
- Parexel: Large global CRO with dedicated pharmacovigilance and safety services across clinical and post-marketing — overlapping competitor for outsourced PV mandates.
- IQVIA: Global CRO and life sciences services giant with a sizable pharmacovigilance practice offering safety reporting, signal management, and QPPV — relevant incumbent competing for the same pharma PV outsourcing budgets.
- ICON plc: Major CRO providing clinical and post-marketing pharmacovigilance services including case processing, aggregate reporting, and safety database management — broad incumbent in the same space.
Emerging players
- PharmaLex: Specialized regulatory and pharmacovigilance services provider covering safety reporting, QPPV, and risk management — comparable PV-focused services, larger scale than Vigipharm.
- Worldwide Clinical Trials: Mid-sized CRO with a dedicated pharmacovigilance and safety services practice — comparable safety-services offering targeting small and mid-cap pharma sponsors.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat4 records
Key risks4 records
Key highlights3 records
Customer concentration
Vigipharm social profiles
Digital presenceVigipharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vigipharm leadership team
Management profileNumber of profiles
Vigipharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vigipharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vigipharm
What does Vigipharm do?
Vigipharm is a health vigilance company that delivers health product safety monitoring services. The firm monitors the safety profile of health products and helps clients detect, evaluate, and manage risks associated with pharmaceutical and other health-related products throughout their lifecycle.
When was Vigipharm founded?
Vigipharm was founded in 1998. It employs 11 to 50 people.
Where is Vigipharm based?
Vigipharm is headquartered in Montpellier, France, in the Europe region.
Who are Vigipharm's main competitors?
Direct peers on record are Arriello, PharSafer, PrimeVigilance and Pharmacovigilance Services Ltd (PVSL). Broad incumbents are Syneos Health, Parexel, IQVIA and ICON plc. Emerging players are PharmaLex and Worldwide Clinical Trials.
Does Vigipharm have an API?
No public API is recorded for Vigipharm.
What industry is Vigipharm in?
Vigipharm's product category is Pharmacovigilance Services. Its primary akta.pro industry code is HLAGALAK, Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support), with a secondary code of HLAGALAL, Literature Monitoring & Social/Digital Media Safety Monitoring. Its SIC code is 8734.